Net Cash Provided by (Used in) Financing Activities of IN8BIO, INC. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IN8BIO, INC. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • IN8BIO, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $3,893,000.
  • IN8BIO, INC. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $28,638,000, a 102% increase from 2024.
  • IN8BIO, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $14,184,000, a 48% decline from 2023.
  • IN8BIO, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $27,044,000, a 201% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

IN8BIO, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $28,638,000 +$14,454,000 +102% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $14,184,000 -$12,860,000 -48% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $27,044,000 +$18,056,000 +201% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $8,988,000 -$23,967,000 -73% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $32,955,000 +$8,438,000 +34% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $24,517,000 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY

IN8BIO, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,893,000 +$4,170,000 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $277,000 -$824,000 -151% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $547,000 +$649,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $102,000 +$333,000 +77% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $435,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.